[1]
Mullokulov J., Akhmedov Kh., Anorboev M., “HEAD-TO-HEAD COMPARATIVE EFFICACY OF GOLIMUMAB VS. TOFACITINIB IN REACTIVE ARTHRITIS: A 52-WEEK REAL-WORLD COHORT STUDY FROM UZBEKISTAN”, CAJM, vol. 1, no. 10, pp. 58–64, Dec. 2025, Accessed: Nov. 19, 2026. Available: https://journals.tnmu.uz/index.php/cajm/article/view/3204